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SUMMARY
Recently, reactivation of Chagas disease (meningoencephalitis and/or myocarditis) was included in the list of AIDS-defining
illnesses in Brazil. We report a case of a 52-year-old patient with no history of previous disease who presented acute meningoencephalitis.
Direct examination of blood and cerebrospinal fluid (CSF) showed Trypanosoma cruzi. CSF culture confirmed the diagnosis. Serological
assays for T. cruzi and human immunodeficiency virus (HIV) were positive. Despite treatment with benznidazol and supportive
measures, the patient died 24 hours after hospital admission. In endemic areas, reactivation of Chagas disease should always be
considered in the differential diagnosis of meningoencephalitis among HIV-infected patients, and its presence is indicative of AIDS.
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INTRODUCTION
Chagas disease or American trypanosomiasis is endemic in Latin
America and is caused by the flagellated protozoan Trypanosoma cruzi,
and generally transmitted to humans by triatomine dejections. It can
also be transmitted through blood transfusions and contaminated
hemoderivates, needles and by syringe sharing among intravenous drug
users, besides congenital transmission9,25.
Globally, Chagas disease represents the third most important tropical
disease, after malaria and schistosomiasis20. In the Americas, there have
been successful experiences regarding the control of Chagas disease
vectorial transmission. Nevertheless, there are an estimated 11 million
chronic cases of infection by T. cruzi13. In Brazil, some 3 to 5 million
individuals are infected and, despite important progress achieved in recent
years, there are still isolated reports of acute cases4,10, and also of blood
transmission through intravenous drug users in several states and regions
(Rio Grande do Sul, Minas Gerais, and Northeast)13,16,19,20,25. The
progressive increase of Chagas disease cases in urban populations, as a
result of massive migration from rural areas to major cities, associated
to the interiorization of the epidemic infection caused by the human
immunodeficiency virus (HIV)7, have created the conditions for
emergence of a higher number of co-infection cases. Consequently, in
the presence of severe immunodeficiency there is a possibility of chronic
Chagasic infection reactivation, which is manifested by severe forms of
neurological (75 - 90% of cases) or myocardial (30% of cases)
involvement15,18-20,24,25,27.
Several studies have demonstrated the opportunistic nature of Chagas
disease reactivation in AIDS patients9,12,14-18,28, which suggests that it
should be considered an AIDS-defining illness1,11,20,26. Despite that
established by the Centers for Disease Control and Prevention8, the
Brazilian Ministry of Health has recently included reactivation of Chagas
disease (meningoencephalitis and/or myocarditis) in the list of AIDS-
defining events6. The potential advantages of this decision, include
improved surveillance of HIV-associated Chagas disease, increased
number of studies related to this co-infection, and provision of social
benefits for the affected patients1.
In this study, we report a case of chagasic meningoencephalitis that
led to the diagnosis of HIV infection, and which defined AIDS.
CASE REPORT
A 52-year-old heterosexual male was admitted to the hospital with a
seven-day history of fever, headache and asthenia, and three days with
altered level of consciousness. He had lost approximately 30 kg weight
during the previous year. His medical history was unremarkable, as well
as the use of intravenous drugs and blood transfusions. He had spent his
childhood and adolescence in a rural area in Bahia but has lived
continuously in an urban area of São Paulo for 33 years prior to becoming
ill. On physical examination, he presented fever (38.5 oC), hypotension
(90/60 mmHg), tachycardia, tachydyspneia, neck stiffness, and mental
state alterations. Pulmonary auscultation revealed bilateral crepitation.
He did not present papilledema, lateralizing signs (e.g. hemiparesis or
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hemianoptic field defect), or focalizing signs (e.g. aphasia). A blood
count revealed hemoglobin = 13.3 mg/dL and leukocytes = 10,200 cells/
mm3 (92% neutrophils, 7% lymphocytes, 1% monocytes). Biochemical
test did not detect any alterations. Due to the severity of illness it was
not possible to perform brain computed tomography (CT). A careful
lumbar puncture was performed which found 16 cells (94% lymphocytes,
4% monocytes, 1% neutrophils, 1% eosinophils), protein 721 mg/dL,
and glucose 0 mg/dL. Direct examination of CSF showed numerous
forms of T. cruzi trypomastigote (Fig. 1), and CSF culture confirmed the
diagnosis. Blood and CSF cultures for bacteria, fungi, and mycobacteria
showed no growth. Serological assays for T. cruzi (indirect
immunofluorescence, passive hemagglutination and enzyme linked
immunoassay (ELISA)) were reagent. The xenodiagnosis was positive.
A rapid test for HIV was reagent, which was later confirmed with ELISA
and Western Blot. Benznidazol 5mg/kg/day twice daily was initiated.
The patient was transferred to the Intensive Care Unit and placed under
mechanical ventilation and hemodynamic support. Despite these
measures, the patient developed neurological deterioration and multiple
organ failure (respiratory insufficiency, oligoanuria, and shock) and died
24 hours after admission. Necropsy revealed findings compatible with
brain edema, meningoencephalitis and an extensive area of necrosis in
the right cerebellar region. Signs of dilated myocardiopathy and bilateral
pulmonary congestion were observed. There were no findings of
megacolon or megaesophagus.
DISCUSSION
DEL CASTILLO et al.12 reported in 1990, for the first time, the
association of central nervous system (CNS) Chagas disease and HIV
infection. FERREIRA et al.14, one year later, described the first case in
Brazil.
To date, approximately 90 cases have been described of Chagas
disease reactivation in AIDS patients, especially in Brazil and Argentina.
However, a detailed description has only been given for a small number
of these. The majority of cases were communicated in specialized
congresses and symposiums18,20. The inclusion of Chagas disease
reactivation in the list of AIDS-defining illnesses in Brazil should lead
to a significant increase in the number of such case reports.
Brain expansive lesions, with or without meningoencephalitis,
constitute the most frequent neurological presentation of Chagas disease
reactivation in AIDS patients9,18. The clinical and radiological
manifestations are unspecific and common to several CNS opportunistic
diseases in AIDS patients. In our hospital (Institute of Infectious Diseases
Emílio Ribas, São Paulo, Brazil), when meningeal or
meningoencephalitis syndrome predominates, the main diagnoses are
cryptococcosis, tuberculosis, and syphilis. When brain expansive lesion
syndrome predominates, the main diagnoses include toxoplasmosis,
tuberculosis (tuberculomas and/or abscesses), and CNS primary
lymphoma (Vidal & Penalva de Olivera, unpublished data). Consequently,
it is necessary to maintain a high level of suspicion for Chagas disease.
A detailed epidemiological history, including current and past residency
in Chagas disease endemic areas, use of intravenous drugs, and blood or
hemoderivative transfusion, is helpful in suggesting a diagnosis.
The laboratorial diagnosis of CNS Chagas disease reactivation
included serology test for T. cruzi, direct examination of blood smears,
neuroimages, and CSF analysis16,22. The greater or lesser contribution of
the last two methods will depend upon the current neurological syndrome
(brain expansive lesion or meningoencephalitis, respectively). It is
important to emphasize that a positive result for blood culture and
xenodiagnostic, should not be interpreted as absolute evidence of
reactivation, in view of the positive results of these tests in chronic
chagasic patients16.
Direct examination of CSF specimens could be a useful method for
early and rapid diagnosis. A typical presentation of chagasic
meningoencephalitis includes mild lymphocytosis (< 100 cells/mL), low
glucose levels, increased protein, and T. cruzi trypomastigote forms in
the CSF centrifuged, or after staining techniques9,18.
The majority of AIDS patients with Chagas disease reactivation
present CD4+ lymphocytes count < 200 cells/µL, similar to those observed
in other AIDS opportunistic neurological diseases18.
The current algorithms of brain expansive lesions management were
carried out in Chagas disease non-endemic areas2,23. Classically, if the
images show one or more expansive lesions, it is recommended to initiate
anti-Toxoplasma specific therapy for 10 to 14 days. A lack of therapeutic
response after this period indicates the need for carrying out stereotaxic
biopsy. In certain circumstances, a surgical approach must be precipitated,
such as in patients with negative IgG serology for T. gondii and single
brain lesion, or when indicated at the therapeutic level2. However, high
levels of suspicion of alternative cerebral toxoplasmosis diagnoses, as
has been already reported in one case of cytomegaloviruses5 and in
another of brain tuberculous abscess29, could also indicate the need for
early biopsy. Interestingly, MONTERO et al.22 proposed a diagnostic
algorithm for focal brain lesions in Chagas disease endemic areas.
Due to the high lethality, suspicion of Chagas disease reactivation
must lead to more intensive diagnostic approaches, including early brain
biopsy if it is not possible to reach the diagnostic through less invasive
methods.
Fig. 1 - Trypanosoma cruzi trypomastigote forms in cerebrospinal fluid (Leishman, 40X).
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In recent years, the availability of molecular methods, applying the
polymerase chain reaction (PCR) in CSF led to a shift from brain biopsy
toward a “minimally invasive” approach of focal brain lesions in AIDS
patients. This strategy helped to decrease the number of brain biopsies
and augmented likelihood of in vivo diagnoses3. Recently, LAGES-SILVA
et al.21 reported an AIDS patient with chagasic meningoencephalitis
diagnosed by PCR assay in CSF. Further studies are necessary in order
to evaluate the application of molecular diagnosis in this clinical setting.
The lethality of Chagas disease reactivation in AIDS patients is very
high. The majority of cases present a fatal course within 10-20 days
after diagnosis17. However, suitable treatment could help to improve
survival rates. Additionally, several case reports suggest that concomitant
use of antiretroviral therapies and subsequent immunological
reconstitution are vital for a more favorable outcome16,17,28.
The inclusion of Chagas disease reactivation, as an AIDS-defining
illness, should stimulate further physiopathological, epidemiological,
and therapeutic studies on this important coinfection in the next few
years. On the other hand, we expect that other endemic diseases, such as
visceral leishmaniasis, could also be included.
In conclusion, Chagas disease reactivation must be considered in
the differential diagnosis of meningoencephalitis, with or without focal
brain lesions in AIDS patients. High levels of diagnostic suspicion,
including epidemiological information (current or previous residency in
Chagas disease endemic areas and/or use of intravenous drugs), clinical
information (presence of concomitant myocardiopathy), and serological
information (positive test for T. cruzi and/or negative for T. gondii), should
lead to intensive diagnostic approaches. Emphasis should be placed on
initiation of early therapy, which could reduce the case-fatality rate of
this disease.
RESUMO
Meningoencefalite chagásica: relato de caso de doença
recentemente incluida como indicativa de AIDS no Brasil
Recentemente, a reagudização da doença de Chagas (meningo-
encefalite e/ou miocardite) foi incluída na lista de doenças indicativas de
aids no Brasil. Os autores relatam o caso de um paciente de 52 anos de
idade, natural de área rural da Bahia e procedente de uma área urbana de
São Paulo, sem história de doenças prévias e que apresentou menin-
goencefalite aguda. As sorologias e pesquisas parasitológicas diretas no
sangue e no liquido cefalorraquideano (LCR) demonstraram presença de
Trypanosoma cruzi, confirmando-se o diagnóstico mediante cultura do
LCR. O teste rápido assim como os ELISA e Western Blot diagnosticaram
infecção pelo vírus da imunodeficiência humana (HIV). Apesar do
tratamento com benzonidazole e as medidas de suporte, o paciente faleceu
24 horas depois da admissão hospitalar. Em áreas endêmicas, a
reagudização da doença de Chagas deve ser sempre considerada no
diagnóstico diferencial das meningoencefalites e sua presença em pacientes
com infecção pelo HIV é indicativa de aids.
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